🔎 Trials Near Me

Почетна › Беркитов лимфом › Охајо › Cincinnati

Kliničke studije za Беркитов лимфом u gradu Cincinnati, OH

13 studija za Беркитов лимфом traži učesnike na lokacijama u gradu Cincinnati i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

Тражи се учесникФаза 1
  • Cincinnati Children's Hospital, Cincinnati
Узраст од 0 до 18 · Оба пола · Ажурирано 13. 11. 2026. · NCT06173518

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

Тражи се учесникФаза 2
  • University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
  • University of Cincinnati Cancer Center-West Chester, West Chester · 15 ми удаљено
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT03739814

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Тражи се учесникФаза 2
  • Cincinnati Children's Hospital Medical Center, Cincinnati
Узраст од 1 до 30 · Оба пола · Ажурирано 12. 11. 2026. · NCT04546399

A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia

Тражи се учесникФаза 3
  • Cincinnati Children's Hospital Medical Center, Cincinnati
Узраст 1 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07223021

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Тражи се учесникФаза 3
  • University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
  • University of Cincinnati Cancer Center-West Chester, West Chester · 15 ми удаљено
Узраст од 18 до 39 · Оба пола · Ажурирано 3. 11. 2026. · NCT03150693

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Тражи се учесникОпсервациона студија
  • Cincinnati Children's Hospital Medical Center, Cincinnati
Узраст од 0 до 38 · Оба пола · Ажурирано 29. 10. 2026. · NCT06131801

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Тражи се учесникФаза 2
  • Cincinnati Children's Hospital Medical Center, Cincinnati
365 Days · Оба пола · Ажурирано 27. 10. 2026. · NCT06317662

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

Тражи се учесникФаза 3
  • University of Cincinnati Medical Center, Cincinnati
Узраст 18 и старији · Оба пола · Ажурирано 14. 10. 2026. · NCT07648264

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Тражи се учесникФаза 3
  • Cincinnati Children's Hospital Medical Center, Cincinnati
365 Days – 25 Years · Оба пола · Ажурирано 25. 8. 2026. · NCT03959085

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Тражи се учесникФаза 2
  • Cincinnati Children's Hospital Medical Center, Cincinnati
Узраст од 7 до 25 · Оба пола · Ажурирано 19. 8. 2026. · NCT05082519

Study of Inotuzumab Ozogamicin, Venetoclax, and Dexamethasone for Relapsed B-cell ALL

Тражи се учесникФаза 1
  • Cincinnati Children's Hospital Medical Center, Cincinnati
Узраст од 1 до 39 · Оба пола · Ажурирано 18. 2. 2026. · NCT06863259

Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies

Тражи се учесникФаза 1
  • University of Cincinnati, Cincinnati
Узраст 18 и старији · Оба пола · Ажурирано 15. 11. 2024. · NCT06034275

Studije za Беркитов лимфом u drugim gradovima

Ostale studije u gradu Cincinnati

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.